- A practical guide to understanding, using and including patient reported outcomes in clinical trials in ovarian cancer
-
Wilson MK, Mercieca-Bebber R, Friedlander M
- KMID: 2417469
- J Gynecol Oncol.
- 2018 Sep;29(5):e81.
- doi: 10.3802/jgo.2018.29.e81
Health related quality of life (HRQOL) is a key priority for patients with ovarian cancer as there is significant morbidity associated with the disease and the treatment. It is therefore... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III epithelial OVArian, fallopian tube and primary peritoneal cancer (ANZGOG1901/2020)
-
Farrell R, Burling M, Lee YC, Pather S, Robledo K, Mercieca-Bebber R, Stockler M, on behalf of the HyNOVA Protocol Steering Committee
- KMID: 2536007
- J Gynecol Oncol.
- 2022 Jan;33(1):e1.
- doi: 10.3802/jgo.2022.33.e1
Background Ovarian cancer is the most lethal gynecological cancer, causing over 200,000 deaths worldwide in 2020. Initial standard treatment for primary ovarian cancer is optimal cytoreductive surgery (CRS) preceded and/or followed... -
- CITED
-
- Close
- SHARE
-
- Close
